Dabur India's Dadra Plant Red-Flagged by US FDA Over Contamination, Falsified Records
The US FDA cited Dabur India's Dadra and Nagar Haveli facility for microbiological contamination risks, equipment maintenance lapses, falsified manufacturing records, and a live bird found in a raw material warehouse. The flags raise compliance concerns for the company's US-bound Ayurvedic and OTC healthcare exports.
US FDA flagged Dabur India's Dadra and Nagar Haveli plant for microbiological contamination risks, equipment maintenance lapses, falsified manufacturing records, and a live bird in a raw material warehouse, raising compliance concerns for its US-bound Ayurvedic and OTC healthcare products.
Why this matters
The Dadra observations escalate scrutiny of Dabur's US export pipeline, with multiple recent reports highlighting data integrity and contamination lapses at the same facility.
Retail-company signals steady at 1,472 over the last 90 days.